What are senolytics?

Senolytics are interventions intended to remove certain senescent cells, but most longevity claims remain early.

Published Jun 1, 2026Updated Jun 27, 2026Reviewed Jun 27, 20265 min read

Simple answer

Senolytics are proposed interventions that target some senescent cells. The idea is scientifically serious, but broad consumer longevity use is not established.

At a glance

Evidence:Mostly lab/animalRisk:High riskStatus:Experimental

What the source says

Senolytic research spans animal studies, early human trials and disease-specific contexts.
Some candidates are supplements, while others are prescription medicines studied in specific settings.
Selectivity, timing and adverse effects are central questions.

What it does not prove

It does not prove consumer anti-aging benefit.
It does not prove combinations are appropriate.
It does not prove senescent-cell removal is safe in every context.

Practical takeaway

Treat senolytics as an active research area, not a casual self-experiment category.

Ask a qualified clinician if

you are considering drug-based senolytic claims, have cancer history, immune concerns or take prescription medicines.

What to watch next

Human trials with disease and function endpoints.
Safety data for drug-based candidates.
Better biomarkers of senescent-cell burden.

FAQs

Are fisetin and quercetin senolytics?

They are discussed as candidates in the literature, but consumer benefit claims need human outcome evidence.

Why are drug-based senolytics higher risk?

Some candidates affect pathways with meaningful medical risks and need clinician oversight.

Source links

PubMed - NIH / NLM
Primary literature search starting point.
ClinicalTrials.gov - NIH / NLM
Registry for trial status, endpoints and sponsors.

Get the weekly longevity evidence briefing.

One plain-English email on the claims, studies and regulatory updates worth knowing - without protocols, hype or miracle claims.

No protocols. No miracle claims. No spam.

I'm new to longevityPeptides and regulationRapamycin and longevity drugsNAD and supplementsGene therapy frontierBiological age and testing

What are senescent cells?

Senescent cells are part of aging biology, but they are not simply bad cells to eliminate everywhere.

Evidence:Early theory

Updated Jun 27, 2026 · 5 min read

Read the guide

Guide

The longevity stack problem: why combinations are hard to interpret.

When multiple interventions change at once, impressive stories become hard to assign to any one ingredient.

Evidence:Evidence unclear